BLIS K12 Probiotics

ENT Health

Regular price
Sale price
Regular price
Sold out
Unit price

  • Inhibits a wide range of oral pathogens
  • Competitively blocks binding of S. pyogenes to human cells
  • Epidemiological studies support the protective role BLIS K12™ plays in preventing tonsillitis and ear infections
  • Granted no objection GRAS status (Generally Recognized as Safe)
  • 30 Lozenges
  • Blister Packs and Box
  • 2.5-5b CFU
  • Shelf-stable, 24 months